The Globe and Mail reports in its Friday, Nov. 7, edition that TD Cowen analyst Derek Lessard has reaffirmed his "buy" recommendation for Savaria. The Globe's David Leeder writes in the Eye On Equities column that Mr. Lessard gave his share target a $3 boost to $27. Analysts on average target the shares at $26.06. Mr. Lessard says in a note: "With Savaria's entrenched industry position, tariff mitigation measures and a healthy balance sheet, we are confident that it can navigate today's market challenges. The next catalyst we're looking for will stem from initiatives focused on sales growth which should further drive operating leverage given Savaria's newly streamlined processes and scale. We expect more details in the coming months." The Globe reported on Jan. 28 that Mr. Lessard had reaffirmed his "buy" recommendation for Savaria. The shares could then be had for $19.75. The Globe reported on Aug. 22 that Stifel analyst Justin Keywood was keeping his "buy" call on Savaria intact. The shares could then be had for $21.15.